Fibrinolytic activity and coronary-artery disease.
作者信息
Naimi S, Proger S
出版信息
Lancet. 1968 Jun 8;1(7554):1250-1.
PMID:4172804
Abstract
摘要
相似文献
1
Fibrinolytic activity and coronary-artery disease.纤溶活性与冠状动脉疾病
Lancet. 1968 Jun 8;1(7554):1250-1.
2
Effect of fibrinolytic treatment in malignant atrophic papulosis.纤溶治疗在恶性萎缩性丘疹病中的作用。
Br Med J. 1975 Aug 16;3(5980):415. doi: 10.1136/bmj.3.5980.415.
3
Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).苯乙双胍与乙基雌烯醇治疗复发性深静脉血栓形成（DVT）
Folia Haematol Int Mag Klin Morphol Blutforsch. 1976;103(3):372-80.
4
Oral fibrinolytic agents.口服纤维蛋白溶解剂。
Br Med J. 1968 Aug 24;3(5616):498. doi: 10.1136/bmj.3.5616.498-a.
5
Malignant atrophic papulosis of Degos. Report of a patient who failed to respond to fibrinolytic therapy.德戈斯恶性萎缩性丘疹病。1例对纤溶疗法无反应患者的报告。
Arch Dermatol. 1976 Nov;112(11):1582-8. doi: 10.1001/archderm.112.11.1582.
6
[Hypofibrinolysis in acute myocardial infarction (author's transl)].急性心肌梗死中的低纤维蛋白溶解（作者译）
Med Klin. 1974 Nov 22;69(47):1951-5.
7
Fibrinolytic therapy for vasculitis of atrophie blanche.
Arch Dermatol. 1974 May;109(5):664-7.
8
Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.苯乙双胍加乙基雌烯醇用于心肌梗死幸存者：三年试点研究
Lancet. 1972 Sep 16;2(7777):556-9. doi: 10.1016/s0140-6736(72)91956-3.
9
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
Lancet. 1967 Nov 11;2(7524):1008-11. doi: 10.1016/s0140-6736(67)90286-3.
10
Experiences in the use of fibrinolytic agents in Behcet's syndrome.白塞病中使用纤溶药物的经验。
Australas J Dermatol. 1972 Apr;13(1):5-10. doi: 10.1111/j.1440-0960.1972.tb00476.x.
Zotero 插件